UniProt ID | SELPL_HUMAN | |
---|---|---|
UniProt AC | Q14242 | |
Protein Name | P-selectin glycoprotein ligand 1 | |
Gene Name | SELPLG | |
Organism | Homo sapiens (Human). | |
Sequence Length | 412 | |
Subcellular Localization |
Membrane Single-pass type I membrane protein. |
|
Protein Description | A SLe(x)-type proteoglycan, which through high affinity, calcium-dependent interactions with E-, P- and L-selectins, mediates rapid rolling of leukocytes over vascular surfaces during the initial steps in inflammation. Critical for the initial leukocyte capture.; (Microbial infection) Acts as a receptor for enterovirus 71.. | |
Protein Sequence | MPLQLLLLLILLGPGNSLQLWDTWADEAEKALGPLLARDRRQATEYEYLDYDFLPETEPPEMLRNSTDTTPLTGPGTPESTTVEPAARRSTGLDAGGAVTELTTELANMGNLSTDSAAMEIQTTQPAATEAQTTQPVPTEAQTTPLAATEAQTTRLTATEAQTTPLAATEAQTTPPAATEAQTTQPTGLEAQTTAPAAMEAQTTAPAAMEAQTTPPAAMEAQTTQTTAMEAQTTAPEATEAQTTQPTATEAQTTPLAAMEALSTEPSATEALSMEPTTKRGLFIPFSVSSVTHKGIPMAASNLSVNYPVGAPDHISVKQCLLAILILALVATIFFVCTVVLAVRLSRKGHMYPVRNYSPTEMVCISSLLPDGGEGPSATANGGLSKAKSPGLTPEPREDREGDDLTLHSFLP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
42 | Pyrrolidone_carboxylic_acid | LLARDRRQATEYEYL HHHHHHHHCCEEEEC | 54.23 | - | |
42 | Pyrrolidone_carboxylic_acid | LLARDRRQATEYEYL HHHHHHHHCCEEEEC | 54.23 | 11081633 | |
42 | Pyrrolidone_carboxylic_acid | LLARDRRQATEYEYL HHHHHHHHCCEEEEC | 54.23 | 11081633 | |
46 | Sulfation | DRRQATEYEYLDYDF HHHHCCEEEECCCCC | 12.91 | - | |
46 | Sulfation | DRRQATEYEYLDYDF HHHHCCEEEECCCCC | 12.91 | 11081633 | |
48 | Sulfation | RQATEYEYLDYDFLP HHCCEEEECCCCCCC | 12.17 | - | |
48 | Sulfation | RQATEYEYLDYDFLP HHCCEEEECCCCCCC | 12.17 | 11081633 | |
51 | Sulfation | TEYEYLDYDFLPETE CEEEECCCCCCCCCC | 13.14 | - | |
51 | Sulfation | TEYEYLDYDFLPETE CEEEECCCCCCCCCC | 13.14 | 11081633 | |
57 | O-linked_Glycosylation | DYDFLPETEPPEMLR CCCCCCCCCCHHHHC | 52.42 | 11081633 | |
65 | N-linked_Glycosylation | EPPEMLRNSTDTTPL CCHHHHCCCCCCCCC | 45.35 | UniProtKB CARBOHYD | |
67 | Phosphorylation | PEMLRNSTDTTPLTG HHHHCCCCCCCCCCC | 40.70 | - | |
69 | Phosphorylation | MLRNSTDTTPLTGPG HHCCCCCCCCCCCCC | 30.33 | - | |
73 | Phosphorylation | STDTTPLTGPGTPES CCCCCCCCCCCCCCC | 42.40 | - | |
81 | Phosphorylation | GPGTPESTTVEPAAR CCCCCCCCCCCCHHH | 32.95 | - | |
82 | Phosphorylation | PGTPESTTVEPAARR CCCCCCCCCCCHHHH | 31.95 | - | |
111 | N-linked_Glycosylation | TELANMGNLSTDSAA HHHHHCCCCCCCCHH | 21.76 | UniProtKB CARBOHYD | |
143 | O-linked_Glycosylation | PVPTEAQTTPLAATE CCCCCCCCCCCCCCC | 37.11 | OGP | |
157 | Phosphorylation | EAQTTRLTATEAQTT CCHHCCEECCCCCCC | 28.39 | - | |
159 | Phosphorylation | QTTRLTATEAQTTPL HHCCEECCCCCCCCC | 26.98 | - | |
264 | O-linked_Glycosylation | AAMEALSTEPSATEA HHHHHHCCCCCHHHH | 53.41 | OGP | |
287 | O-linked_Glycosylation | RGLFIPFSVSSVTHK CCEEECEECCCEECC | 18.74 | 55824305 | |
289 | O-linked_Glycosylation | LFIPFSVSSVTHKGI EEECEECCCEECCCC | 20.21 | 55824309 | |
290 | O-linked_Glycosylation | FIPFSVSSVTHKGIP EECEECCCEECCCCC | 28.95 | 55824313 | |
292 | O-linked_Glycosylation | PFSVSSVTHKGIPMA CEECCCEECCCCCCC | 21.59 | 55824319 | |
302 | N-linked_Glycosylation | GIPMAASNLSVNYPV CCCCCCCCEEECCCC | 31.44 | UniProtKB CARBOHYD | |
357 | Phosphorylation | HMYPVRNYSPTEMVC CCEECCCCCCCCEEE | 12.88 | 28464451 | |
358 | Phosphorylation | MYPVRNYSPTEMVCI CEECCCCCCCCEEEE | 28.97 | 28464451 | |
360 | Phosphorylation | PVRNYSPTEMVCISS ECCCCCCCCEEEEEC | 30.67 | 26657352 | |
366 | Phosphorylation | PTEMVCISSLLPDGG CCCEEEEECCCCCCC | 15.14 | 28450419 | |
367 | Phosphorylation | TEMVCISSLLPDGGE CCEEEEECCCCCCCC | 17.64 | 28464451 | |
376 | Phosphorylation | LPDGGEGPSATANGG CCCCCCCCCCCCCCC | 19.25 | 27251275 | |
377 | Phosphorylation | PDGGEGPSATANGGL CCCCCCCCCCCCCCC | 49.46 | 26074081 | |
379 | Phosphorylation | GGEGPSATANGGLSK CCCCCCCCCCCCCCC | 25.62 | 27080861 | |
385 | Phosphorylation | ATANGGLSKAKSPGL CCCCCCCCCCCCCCC | 33.57 | 26074081 | |
388 | Ubiquitination | NGGLSKAKSPGLTPE CCCCCCCCCCCCCCC | 62.00 | 29967540 | |
389 | Phosphorylation | GGLSKAKSPGLTPEP CCCCCCCCCCCCCCC | 29.12 | 25159151 | |
393 | Phosphorylation | KAKSPGLTPEPREDR CCCCCCCCCCCCCCC | 31.36 | 23401153 | |
404 | Ubiquitination | REDREGDDLTLHSFL CCCCCCCCCCCHHCC | 53.03 | 29967540 | |
405 | Phosphorylation | EDREGDDLTLHSFLP CCCCCCCCCCHHCCC | 6.98 | 27251275 | |
406 | Phosphorylation | DREGDDLTLHSFLP- CCCCCCCCCHHCCC- | 29.44 | 28122231 | |
409 | Phosphorylation | GDDLTLHSFLP---- CCCCCCHHCCC---- | 31.43 | 23401153 | |
422 | Phosphorylation | ----------------- ----------------- | 24719451 | ||
425 | Phosphorylation | -------------------- -------------------- | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SELPL_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SELPL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SELPL_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SELPL_HUMAN | SELPLG | physical | 10713099 | |
LYAM3_HUMAN | SELP | physical | 10713099 | |
MOES_HUMAN | MSN | physical | 12115638 | |
TNIP1_HUMAN | TNIP1 | physical | 17632516 | |
P85A_HUMAN | PIK3R1 | physical | 17632516 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
O-linked Glycosylation | |
Reference | PubMed |
"Insights into the molecular basis of leukocyte tethering and rollingrevealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1."; Somers W.S., Tang J., Shaw G.D., Camphausen R.T.; Cell 103:467-479(2000). Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 42-68 IN COMPLEX WITH SELEAND SELP LECTIN/EGF DOMAINS, SULFATION AT TYR-46; TYR-48 AND TYR-51,GLYCOSYLATION AT THR-57, AND PYROGLUTAMATE FORMATION AT GLN-42. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND THR-393, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND THR-393, ANDMASS SPECTROMETRY. | |
Sulfation | |
Reference | PubMed |
"Insights into the molecular basis of leukocyte tethering and rollingrevealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1."; Somers W.S., Tang J., Shaw G.D., Camphausen R.T.; Cell 103:467-479(2000). Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 42-68 IN COMPLEX WITH SELEAND SELP LECTIN/EGF DOMAINS, SULFATION AT TYR-46; TYR-48 AND TYR-51,GLYCOSYLATION AT THR-57, AND PYROGLUTAMATE FORMATION AT GLN-42. |